Precipitation Patents (Class 530/418)
-
Publication number: 20100331530Abstract: Method for purifying therapeutic proteins by multi-stage extractive distillation.Type: ApplicationFiled: February 25, 2009Publication date: December 30, 2010Applicant: BAYER TECHNOLOGY SERVICES GMBHInventors: Werner Bäcker, Sven Sommerfeld, Martina Mutter, Paula Alexandra Albuquerque De Jesus Rosa, Maria Raquel Murias Dos Santos Aires-Barosl, Ana Margarida Nunes Da Mata Pires De Azevedo
-
Publication number: 20100292446Abstract: The invention provides a method for the separation and purification of two or three cellular components selected from genomic DNA, RNA and proteins from a single biological sample. The method comprises generating an aqueous solution containing the cellular components by lysing cells with a lysis solution; contacting the aqueous solution with an ion exchanger for genomic DNA and RNA to bind to the ion exchanger; collecting the flow-through which contains unbound proteins; eluting RNA from the ion exchanger; and eluting DNA from the ion exchanger. For the purification of any two of the cellular components, one of the components is not collected. The invention also provides reagent kits for carrying out the methods.Type: ApplicationFiled: February 5, 2009Publication date: November 18, 2010Applicant: GE HEALTHCARE BIO-SCIENCES CORP.Inventors: Sudhakar Rao Takkellapati, Joseph W. Farchaus
-
Patent number: 7820801Abstract: A method for producing solid proteinase K which is insoluble in water and has high purity, the method comprising the steps of adding to an aqueous solution of proteinase K ammonium sulfate in an amount of 0.1 to 0.2 M per 5 minutes up to a final amount of 1.5 to 2 M after 1 hour, thereby precipitating the proteinase K as a solid, and isolating the solid proteinase K.Type: GrantFiled: September 29, 2006Date of Patent: October 26, 2010Assignee: Roche Diagnostics Operations, Inc.Inventors: Helmut Schoen, Guenter Guertler, Bernhard Rexer, Johann-Peter Thalhofer
-
Patent number: 7777012Abstract: The invention relates to a method of preparing a protein aggregate, wherein an aqueous protein solution is acidified with a pH that lies above the isoelectric point of the protein. In accordance with the invention, a first protein, which through acidification is able to form a protein aggregate, is acidified in the presence of a second protein in the aqueous solution in order to form a coaggregate comprising the first and second protein, wherein the second protein under identical temperature conditions and pH does not form a protein aggregate in the absence of the first protein. Acidification preferably occurs with the aid of CO2.Type: GrantFiled: March 15, 2005Date of Patent: August 17, 2010Assignee: Technische Universiteit DelftInventors: Marijana Golubovic, Marcel Ottens, Geert Jan Witkamp, Lucas Antonius Maria Van Der Wielen
-
Patent number: 7771725Abstract: The invention concerns a new medicinal product for the treatment of arboviruses, i.e.. a concentrate of immunoglobulins and F(ab)?2 and/or Fab fragments specific to said arbovirus as well as its process of preparation.Type: GrantFiled: April 2, 2007Date of Patent: August 10, 2010Assignee: Laboratoire Fancais du Fractionnement et des BiotechnologiesInventor: Roland Schmitthaeusler
-
Publication number: 20100145021Abstract: A process for enhancing the recovery yield of proteins, especially plasma proteins, from sources containing the proteins, wherein the sources containing the proteins are frozen at temperatures of ??70° C., and the proteins from a frozen source after thawing are further processed in a per se known manner.Type: ApplicationFiled: January 25, 2008Publication date: June 10, 2010Inventor: Wolfgang Marguerre
-
Publication number: 20100095749Abstract: The present invention provides a technique for crystallizing a desired protein at a high probability; namely, a protein crystallizing agent and a method of crystallizing protein. The present invention also provides a technique for determining the conditions for protein crystallization easily with high efficiency; namely, a method of screening the conditions for protein crystallization and a protein crystallization screening reagent. As the protein crystallizing agent, at least one compound selected from the group consisting of a basic amino acid, acidic amino acid, ester derivative of amino acid and amide derivative of amino acid is used, or at least one of these compounds is used in combination with another protein crystallizing agent.Type: ApplicationFiled: September 19, 2007Publication date: April 22, 2010Inventors: Hiroshi Yamaguchi, Len Ito
-
Publication number: 20100087633Abstract: A method for extracting proteins from heterogeneous fluids by precipitation using microfluidics. The method uses an automated protocol for precipitation of proteins onto surfaces, rinsing the precipitates to remove impurities, and resolubilization in buffer for further analysis. The method is compatible with proteins representing a range of different physicochemical properties, as well as with complex mixtures such as fetal bovine serum and cell lysate. In all cases, the quantitative performance (measured using a fluorescent assay for % recovery) was comparable to that of conventional techniques, which are manual and require more time.Type: ApplicationFiled: October 8, 2008Publication date: April 8, 2010Inventors: Aaron R. Wheeler, Mais J. Jebrail
-
Patent number: 7674885Abstract: The invention provides methods for concentrating a macromolecule from a solution comprising the macromolecule and an organic polymer by first subjecting the solution to ultrafiltration to produce a first retentate solution, then adjusting the conductivity of the first retentate solution such that any protein precipitation induced by the organic polymer is essentially prevented to produce a second retentate solution, and then subjecting the second retentate solution to ultrafiltration. In a preferred embodiment, the conductivity is adjusted by diafiltration against water, suitable diluent or buffer. Preferably, the invention pertains to the concentration of solutions of native or recombinant proteins. The invention further pertains preferably to methods for the concentration of cell culture supernatant comprising a product protein and organic polymers of the PLURONIC family of nonionic block co-polymers, and more preferably comprising PLURONIC F-68 nonionic block co-polymer.Type: GrantFiled: November 1, 2003Date of Patent: March 9, 2010Assignee: Bayer HealthCare LLCInventors: Konstantin Konstantinov, Huong Nguyen, Jens H. Vogel
-
Publication number: 20090324650Abstract: A method for the production of a purified extract of natural allergens comprising the steps of a) extracting a natural source of allergens comprising allergenic proteins to form an extract, b) purifying of said extract to remove non-protein components to form a purified extract c) denaturating said purified extract to form a purified denaturated extract, said purified denaturated extract comprising proteins, wherein the most abundant (w/w) proteins, forming together at least 60% (w/w) of all proteins, are at least two proteins, and all proteins represent at least 60% (w/w) of the dry weight of the purified denaturated extract and a method for the production of a purified extract of natural allergens comprising the steps of a) hydrolysing a denaturated allergen to form an allergen hydrolysate, b) purifying said allergen hydrolysate to remove peptides with a molecular weight above 10,000 Da and below 1,000 Da in order to obtain a purified hydrolysate where 70%, more preferably 80% of the peptides are betweType: ApplicationFiled: June 28, 2007Publication date: December 31, 2009Inventors: Thierry Legon, Sabine Pirotton, Gael Placier, Gilles Kergoat
-
Publication number: 20090264632Abstract: The invention relates to a microfluidic device for promoting crystallisation of target molecules, such as proteins. The device comprises a solid structure with a top face and an opposite bottom face and with a least one liquid channel. The liquid channel comprises a target molecule solution inlet and at least two precipitant inlets. The target molecule solution inlet is in liquid communication with each of the precipitant inlets through the liquid channel. The liquid channel comprises a branching channel section adjacent to the target molecule solution inlet, crystallisation channel sections adjacent to the respective precipitant inlets and flow break channel sections arranged between the branching channel section and each of the crystallization channel sections.Type: ApplicationFiled: June 27, 2007Publication date: October 22, 2009Inventor: Morten Sommer
-
Publication number: 20090258426Abstract: The invention is directed to preferred repeat sequences of Neural Thread Protein (NTP), peptides, mimetics, antibodies, and nucleic acids of the preferred sequences, and diagnostic and therapeutic methods of using such preferred NTP sequences.Type: ApplicationFiled: July 23, 2007Publication date: October 15, 2009Inventors: Judith Fitzpatrick, Paul Averback, Maggie Focht, Riza Bibiano
-
Patent number: 7585955Abstract: A process for separating a protein from a sample containing a mixture of proteins is disclosed. The process comprises forming an aqueous combination comprising the sample and an ion exchange material at a pH which is less than the pI of a first fraction of the proteins in the aqueous dispersion but greater than the pI of a second fraction of the proteins in the aqueous dispersion. The aqueous dispersion may then be intensely mixed, causing a fraction of the proteins in the combination to bind to the ion exchange material, and, optionally, centrifuged, causing the combination to stratify into a concentrated solids fraction and a supernatant, the supernatant containing the fraction of the proteins that did not bind to the ion exchange material. This process, including the steps of intense mixing and centrifugation, requires no expensive, specialized instrumentation, can be quickly performed, and is carried out in non-denaturing conditions, allowing for the separated proteins to be further studied.Type: GrantFiled: March 2, 2006Date of Patent: September 8, 2009Assignee: Florida State University Research Foundation, IncInventors: Qing-Xiang (Amy) Sang, Ziad Joseph Sahab
-
Patent number: 7569671Abstract: Methods and apparatus for processing corn into one or more corn products. Oil is extracted from corn or corn products or by-products with a solvent. The corn-solvent mixture is separated into streams, one of which preferably includes an extract containing at least oil and solvent, and another containing de-oiled corn solids and adsorbed solvent. The solvent is separated from oil, and the de-oiled, desolventized corn solids are processed to provide one or more corn products.Type: GrantFiled: January 6, 2006Date of Patent: August 4, 2009Assignee: The Board of Trustees of the University of IllinoisInventor: Munir Cheryan
-
Patent number: 7556835Abstract: The invention relates to a process for isolating edible protein from animal muscle by solubilizing the protein in an alkaline aqueous solution.Type: GrantFiled: September 5, 2001Date of Patent: July 7, 2009Assignee: University of MassachusettsInventors: Herbert O. Hultin, Stephen D. Kelleher, Yuming Feng, Mark P. Richards, Hordur Kristinsson, Ingrid Undeland, Shuming Ke
-
Patent number: 7544784Abstract: The invention provides methods of increasing yields of desired conformation of proteins. In particular embodiments, the invention includes contacting preparations of a recombinant protein with a reduction/oxidation coupling reagent for a time sufficient to increase the relative proportion of a desired configurational isomer.Type: GrantFiled: November 22, 2006Date of Patent: June 9, 2009Assignee: Immunex CorporationInventors: Helmut M. Sassenfeld, Richard L. Remmele, Jr., Rebecca E. McCoy
-
Patent number: 7531632Abstract: Processes and apparati are provided for separating molecules of interest from a mixture by depth filtration (DF). The DF of the invention is useful in the clarification and processing of various feedstreams for the removal of a molecule of interest. According to a preferred embodiment, a transgenic milk feedstream is stabilized and particulate matter such as fat, casein miscelles and bacteria are removed. An aseptic filtration step was also developed to remove any bacteria remaining in a clarified transgenic milk feedstream.Type: GrantFiled: February 16, 2006Date of Patent: May 12, 2009Assignee: GTC Biotherapeutics, Inc.Inventor: Mark A. Perreault
-
Publication number: 20090105120Abstract: Described is a method for selectively isolating tryptophan containing peptides from an aqueous peptide mixture, including the steps of controlling the pH of the aqueous peptide mixture to 4.0-6.0, forming a precipitate of tryptophan containing peptides, and isolating the precipitated peptides. The aqueous peptide mixture is preferably obtained by enzymatic cleavage at acidic pH of a protein source. Further, peptides having a Trp content of 8-15 w/w % and the use thereof as a food additive and as an active ingredient in a medicament are described.Type: ApplicationFiled: October 23, 2008Publication date: April 23, 2009Inventors: Leon Franciscus MALLEE, Petronella Wilhelmina Josephina Rosa Caessens, Johannes Wilhemus Leonardus Boumans
-
Patent number: 7521417Abstract: A process is disclosed for the preparation of an essentially tetramer-free, substantially stroma-free, polymerized, pyridoxylated hemoglobin. Also disclosed is an essentially tetramer-free, substantially stroma-free, polymerized, pyridoxylated hemoglobin product capable of being infused into human patients in an amount of up to about 5 liters.Type: GrantFiled: January 10, 2008Date of Patent: April 21, 2009Assignee: Northfield Laboratories, Inc.Inventors: Richard E. DeWoskin, Marc D. Doubleday
-
Publication number: 20090099343Abstract: Peptide reagents that interact preferentially with the PrPsc form of the prion protein are described. Methods of using the reagents for isolation and purification of the PrPsc isoform are described.Type: ApplicationFiled: January 13, 2006Publication date: April 16, 2009Inventors: David Peretz, Melissa Michelitsch, Celine Hu, David Chien, John Hall, Xuemei Wang, Man Gao
-
Patent number: 7517968Abstract: A method for purifying a membrane protein is disclosed which includes providing a test sample potentially including a target membrane protein; adding incremental amounts of a precipitating agent to the test sample to form one or more mixtures; and treating the one or more mixtures under conditions effective to obtain precipitated, purified target membrane protein if present in the test sample.Type: GrantFiled: July 7, 2004Date of Patent: April 14, 2009Assignee: Syracuse UniversityInventors: Mark S. Braiman, Ranga Partha
-
Patent number: 7494969Abstract: A method of treating cancer dependent on growth factor GHRH in warm-blooded animals in need thereof with an isolated protein extended for Pilocarpus Heterophyllus.Type: GrantFiled: August 25, 2003Date of Patent: February 24, 2009Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)Inventors: Eric Ferrandis, Beng Poon Teng, Christine Sohier, Christophe Thurieau
-
Method for isolation of DNA, RNA and proteins from formalin-fixed paraffin-embedded tissue specimens
Publication number: 20090035761Abstract: Methods are disclosed for rapid, reliable and simple isolation of RNA from formalin-fixed paraffin-embedded tissue samples. RNA purified in this manner can be used to monitor gene expression levels. The tissue sample can be a tumor or other pathological tissue.Type: ApplicationFiled: July 27, 2007Publication date: February 5, 2009Inventors: Kathleen Danenberg, Peter V. Danenberg, Steven Swenson -
Patent number: 7482148Abstract: The present invention relates to a recombinant calf-Chymosin protein as set forth in SEQ ID No. 1; a recombinant calf-Chymosin gene as set forth in SEQ ID No. 2 encoding the protein comprising amino acid sequence of SEQ ID NO.1; an E. coli comprising the recombinant chymosin gene of SEQ ID No. 2; an expression vector pET21b comprising recombinant calf-chymosin gene as set forth in SEQ ID No. 2; and lastly a method for producing recombinant calf-chymosin protein as set forth in SEQ ID No. 1 which comprises steps of isolating calf-chymosin gene, cloning the same in bacterial expression vector pET21b, transforming said cloned vector into cells of E. coli, fermenting said E. coli to produce pro-chymosin, converting said pro-chymosin to chymosin and subsequently recovering the recombinant calf-chymosin.Type: GrantFiled: March 30, 2004Date of Patent: January 27, 2009Assignee: Sudershan Biotech Ltd.Inventors: Venkata Madhusudhan Reddy Mule, Padala Kamala Mythili, Karanam Gopalakrishna, Yamala Ramana, Donthi Reddy Bosu Reddy
-
Patent number: 7473764Abstract: A process is provided for isolating a protein component of animal muscle tissue by mixing a particulate form of the tissue with an acidic aqueous liquid having a pH below about 3.5 to produce a protein rich solution substantially free of myofibrils and sarcomere tissue structure. The protein rich aqueous solution can be treated to effect protein precipitation, followed by protein recovery.Type: GrantFiled: August 9, 2007Date of Patent: January 6, 2009Assignee: Advanced Protein Technologies, IncInventors: Herbert O. Hultin, Stephen D. Kelleher
-
Publication number: 20090005544Abstract: Disclosed is a process comprising: mixing a soy protein-containing material with an aqueous medium; removing the non-solubilized solids from the slurry to form an alkaline liquid containing solubilized soy protein; adjusting the pH of the solubilized soy protein liquid to between about 3.8 and about 6.6, to precipitate soy protein from the liquid; separating the precipitated soy protein from the pH-adjusted soy protein liquid; resolubilizing the separated soy protein precipitate in an aqueous medium at a pH of from about 1.8 to 3.2; treating the resolubilized soy protein with at least one water-soluble calcium salt to form a calcium-enriched soy protein mixture; precipitating soy protein from the calcium-enriched soy protein mixture by adjusting the pH of the mixture to between about 3.8 and about 6.6; separating the precipitated soy protein from the calcium-enriched soy protein mixture; and washing to form calcium-enriched soy protein isolate having selectively reduced manganese concentrations.Type: ApplicationFiled: June 25, 2008Publication date: January 1, 2009Inventors: Louis I. Ndife, Chad R. Cole, Jeffrey H. Baxter
-
Patent number: 7459542Abstract: The present invention generally relates to methods for separating albumin from samples comprising albumin and other proteins based on the pI of albumin. More particularly, the methods relate to forming an aqueous combination comprising the sample and an anion or a cation exchange material at various pHs, agitating the combination, and separating a fraction of unbound proteins from a concentrated solids fraction comprising the ion exchange material and bound proteins.Type: GrantFiled: March 2, 2006Date of Patent: December 2, 2008Assignee: Florida State University Research Foundation, Inc.Inventors: Qing-Xiang (Amy) Sang, Ziad Joseph Sahab
-
Publication number: 20080287661Abstract: Devices and methods are provided for reducing matrix effects in protein precipitated bioanalytical samples comprising: a support, and a sorbent associated with the support capable of binding matrix interfering agents present in the bioanalytical sample, wherein the device further comprises filtering means for removing precipitated protein particles. The filtering means is a size exclusion filter or a polymeric or inorganic monolith having a maximum pore size less than or equal to the diameter of the particles to be removed from the sample, and can be integral with the sorbent or associated with the sorbent. The sorbent is characterized by sufficient selectivity between the matrix interfering agents and analytes of interest to provide retention of the matrix interfering agents while providing elution of the analytes of interest (e.g., a reversed phase or a polar modified reversed phase).Type: ApplicationFiled: May 16, 2007Publication date: November 20, 2008Inventor: David C. Jones
-
Patent number: 7442308Abstract: A process for removing viruses in fibrinogen solutions and fibrinogen obtained thereof wherein the process starts with an adjusted purified fibrinogen solution, the adjusted purified solution is frozen and then thawed at a temperature between 5 and 20° C., the undissolved materials associated with the fibrinogen are subsequently separated, the temperature is adjusted and the resultant solution is finally subjected to nanofiltration using filters having a pore size smaller than 35 nm.Type: GrantFiled: February 25, 2004Date of Patent: October 28, 2008Assignee: Grifols, S.A.Inventors: Pere Ristol Debart, Jesus Fernandez Rodriguez
-
Publication number: 20080255342Abstract: A method for removing contaminant DNA in a sample containing a physiologically active protein, which comprises the following steps: 1) converting the sample containing a physiologically active protein into a neutral aqueous solution of low conductivity; and 2) removing the resulting particles.Type: ApplicationFiled: January 23, 2008Publication date: October 16, 2008Applicant: CHUGAI SEIYAKU KABUSHIKI KAISHAInventors: Kozo TAKEDA, Norimichi Ochi
-
Patent number: 7411044Abstract: A substantially tetramer free hemoglobin solution and a method for producing a substantially tetramer free hemoglobin solution. The method includes polymerizing a solution of hemoglobin, treating the polymerized hemoglobin solution to partially degrade the polymer to tetramer and removing tetramer from the hemoglobin solution.Type: GrantFiled: August 24, 2006Date of Patent: August 12, 2008Assignee: Northfield Laboratories, Inc.Inventors: Anthony Avella, Richard DeWoskin, Marc Doubleday
-
Patent number: 7385037Abstract: Method for the preparation of gliadin- and glutenin-rich fractions from gluten in an aqueous medium and in the presence of an acid, wherein the gluten are dispersed continuously or not in water up to a dry substance varying between 5 and 30%, by which the pH of the dispersion is monitored between 4.4 and 4.8 and the gluten-water mixture is submitted to shearing actions, through which the dispersion, continuously or not, can be fractionated in gliadin- and glutenin-rich fractions, by which a single gliadin-rich fraction with a gliadin/glutenin ratio of at least 2.5 is obtained, and a single glutenin-rich fraction with a gliadin/glutenin ratio of less than 0.8 is obtained.Type: GrantFiled: July 30, 2002Date of Patent: June 10, 2008Assignee: Tate & Lyle EuropeInventor: Stefaan Roels
-
Patent number: 7361734Abstract: A Staphylococcus aureus S8 native crystalline structure and a Staphylococcus aureus S8 mode of binding with rRNA were identified.Type: GrantFiled: October 15, 2002Date of Patent: April 22, 2008Assignee: SmithKline Beecham CorporationInventors: Nestor O. Concha, Richard R. Gontarek, Cheryl A. Janson
-
Patent number: 7259243Abstract: A process for isolation of milk osteopontin from a material containing milk osteopontin by optionally mixing the milk material with a calcium source and separate the osteopontin containing phase from the rest of the milk material by pH adjustment.Type: GrantFiled: January 4, 2001Date of Patent: August 21, 2007Assignee: Arla Foods AmbaInventors: Esben Skipper Sørensen, Steen Ostersen, Dereck Chatterton, Hans Henrick Holst, Kristian Albertsen
-
Patent number: 7244828Abstract: A method of protein precipitation, concentration and removal of non-protein agents from the protein solution wherein the protein solution is treated with a protein-precipitation agent containing an acidic agent, a salt and a precipitate forming agent. After precipitation, the protein precipitate is washed with a water miscible organic solvent agent to remove non-protein agents present in the protein precipitate.Type: GrantFiled: February 3, 2005Date of Patent: July 17, 2007Inventor: Aftab Alam
-
Patent number: 7232894Abstract: Methods for the production of recombinant peptides comprise fermenting cells to produce recombinant peptides. A metal salt is added to a concentrate of the fermented cells after the fermentation step, prior to peptide isolation, and the pH of the cell concentrate after the addition of the metal salt is less than or equal to 7, thereby reducing the amount of trifulsides formed in the production of the recombinant peptide, with the proviso that the production does not include conversion of formed trifulside peptide into native peptide form after the addition of the metal salt. In one embodiment, the recombinant peptide is recombinant growth hormone.Type: GrantFiled: July 5, 1999Date of Patent: June 19, 2007Assignee: Pharmacia ABInventors: Barbro Hemmendorff, Andreas Castan, Anders Persson
-
Patent number: 7229789Abstract: A process is disclosed for releasing proteins from cells and/or inactivating viruses. In the process, a host cell containing a protein of interest is contacted with a solution of an effective amount of a detergent.Type: GrantFiled: January 19, 2001Date of Patent: June 12, 2007Assignee: N.V. OrganonInventor: Scot R. Shepard
-
Patent number: 7214778Abstract: A glycoprotein extracted from the fruiting body of Grifola frondosa is demonstrated to have antidiabetic, antihypertensive, antiobesity and antihyperlipidemic effects, and has great potential as an active component for pharmaceuticals, dietary supplements or health food preparations to treat and/or prevent the above diseases. This invention is to provide the glycoprotein and its preparation method.Type: GrantFiled: January 22, 2004Date of Patent: May 8, 2007Assignee: Masaki ShirotaInventors: Cun Zhuang, Hirokazu Kawagishi, Harry G. Preuss
-
Patent number: 7144988Abstract: Crystals comprising a modified interleukin-1 type 1 receptor (IL-1R1) and one or more modulators of IL-1 activity are described. Methods of identifying potential inhibitors of IL-1 activity are also described. Compositions and methods for the treatment of IL-1 mediated diseases, such as rheumatoid arthritis, osteoarthritis, and other inflammatory conditions, are described.Type: GrantFiled: March 14, 2003Date of Patent: December 5, 2006Assignee: Array Biopharma, Inc.Inventors: Barbara J. Brandhuber, Guy P. A. Vigers
-
Patent number: 7141262Abstract: The invention concerns a method for obtaining a highly enriched TGF-beta protein fraction in activated form, from a liquid solution rich in proteins said to be soluble in the aqueous phase of milk and/or of whey, said method comprising the following steps; a) adjusting soluble proteins purified at a concentration between 5 and 30 g/liter of solution; b) precipitating part of the whey proteins by acidic treatment of the solution thus obtained to a pH ranging between 4 and 5.5 and at a temperature ranging between 55° C. and 68° C.; c) carrying out a microfiltration of the treated solution by diafiltration, so as to obtain respectively a microfiltration retentate and a microfiltrate; d) recuperating the microfiltration retentate containing the protein fraction highly enriched in TGF-beta; e) drying the microfiltration retentate which has been subjected to diafiltration to obtain a powder highly enriched in TGF-beta.Type: GrantFiled: July 12, 2002Date of Patent: November 28, 2006Assignee: Pierre Jouan Biotechnologies S.A.Inventors: Jean-Louis Maubois, Jacques Fauguant, Pierre Jouan, Michel Bourtourault
-
Patent number: 7135553Abstract: A substantially tetramer free hemoglobin solution and a method for producing a substantially tetramer free hemoglobin solution. The method includes polymerizing a solution of hemoglobin, treating the polymerized hemoglobin solution to partially degrade the polymer to tetramer and removing tetramer from the hemoglobin solution.Type: GrantFiled: January 29, 2004Date of Patent: November 14, 2006Assignee: Northfield Laboratories, Inc.Inventors: Anthony Avella, Richard DeWoskin, Marc Doubleday
-
Patent number: 7122642Abstract: A method to prepare new or unexpected polymorphs of materials which have not been observed, or to obtain a known polymorph under different conditions than those in which it is usually made, by using a laser to cause nucleation and crystal growth to occur in a supersaturated solution in such a way as to obtain a crystal structure which would not normally appear without the use of the laser.Type: GrantFiled: January 24, 2002Date of Patent: October 17, 2006Assignee: Polytechnic UniversityInventors: Allan S. Myerson, Bruce A. Garetz
-
Patent number: 7122344Abstract: The present invention relates generally to the production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. More particularly, the invention provides processes, including broadly the steps of bacterial expression and protein purification, for the scaled-up production of rhUG according to current Good Manufacturing Practices (cGMP). The invention further provides analytical assays for evaluating the relative strength of in vivo biological activity of rhUG produced via the scaled-up cGMP processes.Type: GrantFiled: July 2, 2001Date of Patent: October 17, 2006Assignee: Claragen, Inc.Inventors: Aprile L. Pilon, Richard W. Welch
-
Patent number: 7115719Abstract: Reagents, methods and kits for denaturation of protein are provided.Type: GrantFiled: December 15, 2004Date of Patent: October 3, 2006Assignee: Gentra Systems, Inc.Inventor: Kim E. Paulsen
-
Patent number: 7098026Abstract: Disclosed are a novel hedgehog protein, i.e., a Desert hedgehog protein of human origin including mature and precursor forms, a DNA encoding the protein, a monoclonal antibody recognizing the protein, a process for producing the protein, and a method for detecting the protein. The hedgehog protein is useful in establishment of hybridomas which produce antibodies recognizing the protein, and the monoclonal antibody is useful in detection and purification of the protein. The hedgehog protein, DNA, and monoclonal antibody of this invention have efficacy in elucidation of hereditary morphological abnormalities in humans to establish their treatments and diagnoses.Type: GrantFiled: July 14, 2000Date of Patent: August 29, 2006Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku KenkyujoInventors: Toshio Ariyasu, Shuji Nakamura, Kunzo Orita
-
Patent number: 7087719Abstract: The present invention relates to the purification and production of human albumin from various sources through crystallization and repeated crystallization. Basic features of the invented process include providing specific reaction conditions and precipitating reagents to maximize albumin crystallization. Solubility diagrams are utilized as the basis for process control of the invented method. The current invention specifically controls phosphate concentration, pH and temperature to precisely guide crystallization kinetics and crystal yield.Type: GrantFiled: November 19, 2002Date of Patent: August 8, 2006Assignee: GTC Biotherapeutics, Inc.Inventors: Kalevi Visuri, Sinikka Uotila, Scott P. Fulton, Daniel E. Couto
-
Patent number: 7022822Abstract: Purification process of humanPurification process of human urinary gonadotropins of high biological activity and chemical purity absolutely free of foreign contaminating materials derived from the use of biological reagents or chromatography dyes, from crude of gonadotropins. The high biological activity and chemically pure composition of human gonadotropins obtained by this process, are used for the treatment of infertility and are selected from the group of follitropin or menotropins, having a bioactivity greater than 2500 IU/mg protein as tested by biological assay in rats, for both FSH and LH hormones for menotropins and greater than 5000 IU/mg protein for follitropin having an FSH:LH ratio about 75:1. Pharmaceutical preparations of said gonadotropins free of these contaminating materials are also comprised within the present invention.Type: GrantFiled: April 14, 2000Date of Patent: April 4, 2006Assignee: Instituto Massone S.A.Inventors: Claudio Fernando Wolfenson Band, Liliana Ester Balanian, Jose-Felipe Groisman, Erundina Marta Fasanella
-
Patent number: 6995242Abstract: A method of extracting and fractionating collagen-rich proteinaceous materials and derivatives from poultry skin tissue and the development of the proteinaceous materials to collagen-based protein ingredients that can function as meat replacer, texturizer, binder/filler, stabilizer, or protective colloids in processed meat products. The insoluble and soluble collagen products, collagen-based protein ingredients, water-dispersible collagen-based protein ingredients are produced by heating, separating, and rapidly cooling the solid-phase below its melting temperature to exploit reformation of the helical forms which produces a high concentration of coils, a phenomenon that accounts for its ability to form cold-set thermal reversible gels and gel strength.Type: GrantFiled: July 15, 2002Date of Patent: February 7, 2006Assignee: The Lauridsen Group, Inc.Inventors: Ifendu Nnanna, Allen Leinen, David Hull
-
Patent number: 6989436Abstract: The present invention provides methods for preparing, and compositions comprising, stabilized protein-polymer conjugates. More particularly, the present invention relates to the stabilization of individual and complexed subunits of multisubunit protein complexes by conjugation to polymers. Such conjugation acts to stabilize the specific subunit complexes in their native conformation in liquid medium.Type: GrantFiled: February 4, 2003Date of Patent: January 24, 2006Assignee: Medical Analysis Systems, Inc.Inventors: Kirti I. Davé, Brian Robert Fernández
-
Patent number: 6989438Abstract: The present invention concerns a process for the purification of EPI-HNE proteins, from the culture medium of a host strain for the expression of said proteins, comprising the steps of: (a) passing a derived part of the culture medium over an expanded bed of cationic exchange adsorbent or a mechanically and chemically inert micromembrane, in order to recover an eluate, (b) optionally conducting chromatographic separation of proteins, according to their hydrophobicity, on the resulting eluate, (c) passing the resulting eluate over a cationic exchange column, (d) optionally filtering the resulting medium such as to obtain a sterile filtrate, and optionally further comprising the step of (e) causing precipitation of EPI-HNE in a crystallised form and recovering the protein crystals.Type: GrantFiled: August 30, 2001Date of Patent: January 24, 2006Assignee: Debiopharm S.A.Inventors: Alain Poncin, François Saudubray, Anne Bokman